<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=234748540252369&amp;ev=PageView&amp;noscript=1">

Diopsys Insights

Alberto González García, M.D., Chief Medical Officer, Diopsys

Since 2011, Alberto González García, M.D. has lead Diopsys’ extensive clinical research efforts. Dr. González received his medical training at Finlay-Albarran in Havana, Cuba. He completed fellowships in Neuro-Ophthalmology at the National Institute of Neurology and Neurosurgery in Cuba, and in Glaucoma at the Hamilton Glaucoma Center at the University of California San Diego. He was Chief of the Neuro-Ophthalmology Department at the National Institute of Neurology and Neurosurgery and a clinician and surgeon at the National Institute of Ophthalmology in Cuba. He has published and contributed to numerous books and studies in the areas of early diagnosis of glaucoma, ischemic optic neuropathy, and optic coherence tomography (OCT) in the diagnosis of retina and optic nerve diseases, among many others.

Recent Posts

Light Induced Visual-response (LIV)


Light Induced Visual-response (LIV) measures the electrical responses of cells within the eye upon stimulation by a light source. Various stimuli can be used to target different cells within the visual pathway to gain objective information regarding their function, thus allowing clinicians to detect even subtle changes in cell health and viability. But what is the real value of LIV?

With objective, functional data, Light Induced Visual-response allows for tailored treatment and more precise disease management.

Read More

Topics: Visual Electrophysiology

Diabetic Retinopathy Management: An Advanced Approach

Posted by Alberto González García, M.D., Chief Medical Officer, Diopsys on February 1, 2018 at 9:43 AM


Patients with diabetic retinopathy can present difficult clinical questions, even to the most experienced experts. Whether and when to administer treatment and how to gauge effectiveness are topics that have been front and center in eye care for a long time. More fundamentally, understanding precisely how the disease is affecting the health of the eye has proven challenging, because while measurements like vision loss signify disease progression, visual acuity recovery after treatment does not necessarily correlate with improvement in underlying structure and function.

Read More

Topics: Flicker ERG, Diabetic Retinopathy

Modern Visual Electrophysiology

World Leading Technology

As the world leader in modern visual electrophysiology, Diopsys, Inc. has done more than any other company to advance the use of ERG and VEP in the eye care practice. Read through our blog to gain valuable insights into the benefits and integration of this valuable technology.

Subscribe to Email Updates

Recent Posts